0001493152-23-023865.txt : 20230707 0001493152-23-023865.hdr.sgml : 20230707 20230706180925 ACCESSION NUMBER: 0001493152-23-023865 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230630 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230707 DATE AS OF CHANGE: 20230706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reliance Global Group, Inc. CENTRAL INDEX KEY: 0001812727 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 463390293 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40020 FILM NUMBER: 231074729 BUSINESS ADDRESS: STREET 1: 300 BOULEVARD OF THE AMERICAS, STREET 2: SUITE 105 CITY: LAKEWOOD STATE: NJ ZIP: 08701 BUSINESS PHONE: 732-780-4647 MAIL ADDRESS: STREET 1: 300 BOULEVARD OF THE AMERICAS, STREET 2: SUITE 105 CITY: LAKEWOOD STATE: NJ ZIP: 08701 8-K 1 form8-k.htm
0001812727 false 0001812727 2023-06-30 2023-06-30 0001812727 RELI:CommonStock0.086ParValuePerShareMember 2023-06-30 2023-06-30 0001812727 RELI:SeriesWarrantsToPurchaseSharesOfCommonStockParValue0.086PerShareMember 2023-06-30 2023-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest reported): June 30, 2023

 

Reliance Global Group, Inc.

(Exact name of registrant as specified in its charter)

 

Florida   001-40020   46-3390293
(State or other jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification Number)

 

300 Blvd. of the Americas, Suite 105, Lakewood, NJ 08701

(Address of principal executive offices)

 

(732) 380-4600

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CF$ 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on which Registered
Common Stock, $0.086 par value per share   RELI   The Nasdaq Capital Market
Series A Warrants to purchase shares of Common Stock, par value $0.086 per share   RELIW   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On June 30, 2023, Reliance Global Group, Inc. (the “Company”) entered into a Confidential Settlement Agreement and Mutual Release (the “Settlement Agreement”) by and between the Company, Medigap Healthcare Insurance Agency, LLC, a wholly owned subsidiary of the Company (the “Agency” and together with the Company, the “Reliance Parties”), Pagidem, LLC f/k/a Medigap Healthcare Insurance Company, LLC (“Pagidem”), Joseph J. Bilotti, III (together with Pagidem, the “Bilotti Parties”), Kyle Perrin, Zachary Lewis, T65 Health Insurance Solutions, Inc. f/k/a T65 Health Solutions, Inc. (“T65”), and Seniors First Life, LLC (collectively with Mr. Lewis and T65, the “Lewis Parties”).

 

The Company, Pagidem, and Mr. Bilotti previously entered into that certain Asset Purchase Agreement dated December 21, 2021 (the “APA”), pursuant to which the Company acquired, and the Bilotti Parties sold, certain assets and liabilities of Pagidem to the Company. As part of the transactions contemplated by the APA, the Company entered into that certain Employment Agreement, dated as of January 10, 2022, by and between the Company and Mr. Perrin (the “Employment Agreement”). The Company later assigned the assets and liabilities it acquired pursuant to the APA, and the Employment Agreement, to Agency. Mr. Perrin previously served as the Chief Operating Officer and Chief Executive Officer of Agency pursuant to the Employment Agreement. The Company and Mr. Lewis entered into that certain Non-Disclosure Agreement, effective as of January 24, 2022 (the “NDA”).

 

The Company, pursuant to the APA, previously filed a claim with the American Arbitration Association (“AAA”), Case No. 01-23-0002-3404 (the “Bilotti Arbitration”), wherein the Company purports to assert claims against the Bilotti Parties for fraudulent inducement, intentional and negligent misrepresentation, breach of contract, breach of restrictive covenants, conversion, civil theft, tortious interference, and conspiracy (the “Bilotti Claim”). The Company also filed, pursuant to the Employment Agreement, a claim with the AAA, Case No. 01-23-0002-2048(the “Perrin Arbitration”), wherein the Company purports to assert claims against Mr. Perrin for conversion, civil conspiracy, fraud, breach of fiduciary duty, and breach of duty of loyalty and good faith. (the “Perrin Claim”). In the Perrin Arbitration, Mr. Perrin filed counterclaims against the Company for breaches of employment agreement, unjust enrichment, and breach of the covenant of good faith and fair dealing (the “Perrin Counterclaim”).

 

The Reliance Parties have filed a complaint in the Circuit Court of the 15th Judicial Circuit in and for Palm Beach County, Florida, Case No. 50-2023-CA-010777-XXXXMB, Div. AA (the “Lewis Litigation,” and collectively with the Bilotti Arbitration and the Perrin Arbitration, the “Medigap Disputes”), wherein the Reliance Parties purport to assert claims against the Lewis Parties for tortious interference with business relationship, civil conspiracy, breach of contract, conversion, and unjust enrichment (the “Lewis Claim”).

 

The parties to the Settlement Agreement have each disputed and continue to dispute the claims asserted and allegations made against them.

 

United Insurance Group Agency, Inc. and/or LTC Global, Inc. or those entities’ assignees, affiliates, subsidiaries, partners or parent companies (collectively, the “Factor”), allege the Reliance Parties owe the Factor a debt, which the Reliance Parties dispute.

 

Pursuant to the terms of the Settlement Agreement, the Medigap Parties agreed to pay to the Company an amount equal to $2,900,000 (the “Settlement Payment”) within five business days of the effective date of the Settlement Agreement. The Company received the Settlement Payment on July 6, 2023.

 

Upon receipt of the Settlement Payment, the Reliance Parties agreed to release and discharge each and all of the Bilotti Parties, Mr. Perrin, and the Lewis Parties, and each of their present and former agents, servants, or employees, members, owners, shareholders, officers, managers, partners, directors, trustees, representatives, attorneys, contractors, predecessor and successor entities and assigns, parents, subsidiaries and affiliates (collectively, the “Medigap Released Parties”) of and from any and all past, existing, and/or future suits, liabilities, claims, demands, fees, costs, expenses, payments, judgments, damages, actions and rights or causes of action of any kind or nature, from the beginning of the world to the effective date of the Settlement Agreement, including but not limited to (A) any matters that were or could have been alleged in the: (i) the Bilotti Arbitration; (ii) the Perrin Arbitration; (iii) the Lewis Litigation; and (B) (i) any and all claims to additional money, distributions, or compensation of any kind from the Medigap Released Parties; provided, however, that nothing in the Settlement Agreement will serve to release any claims the Reliance Parties may have against the Factor.

 

 
 

 

In addition, upon receipt of the Settlement Payment, the Medigap Parties agreed to release and discharge each and all of the Reliance Parties, and each of their present and former agents, servants, or employees, members, owners, shareholders, officers, managers, partners, directors, trustees, representatives, attorneys, contractors, predecessor and successor entities and assigns, parents, subsidiaries and affiliates (collectively, the “Reliance Released Parties”) of and from any and all past, existing, and/or future suits, liabilities, claims, demands, fees, costs, expenses, payments, judgments, damages, actions and rights or causes of action of any kind or nature, from the beginning of the world to the effective date of the Settlement Agreement, including but not limited to (A) any matters that were or could have been alleged in the: (i) the Bilotti Arbitration; (ii) the Perrin Arbitration; (iii) the Lewis Litigation; and (B) (i) any and all claims to additional money, distributions, or compensation of any kind from the Medigap Released Parties.

 

Also, pursuant to the terms of the Settlement Agreement, Mr. Perrin agreed to release the Reliance Parties from all claims arising under any federal, state or local law or statute, including without limitation, the Fair Labor Standards Act, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Family Medical Leave Act, Title VII of the Civil Rights Act of 1964, Employee Retirement Income Security Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification Act, the law of contract and tort, any claim for attorneys’ fees, claims for unpaid wages or other employment compensation, and claims of personal injury, including mental and physical pain and suffering or intentional infliction of emotional distress. Additionally, Mr. Perrin expressly waived any right to recover any type of personal relief from the Reliance Parties, including monetary damages or reinstatement, in any administrative action or proceeding, whether state or federal, and whether brought by Mr. Perrin or on his behalf by an administrative agency, related in any way to the matters herein.

 

Pursuant to the terms of the Settlement Agreement, all of the parties thereto agreed that, upon receipt of the Settlement Payment by the Reliance Parties, they would discharge any obligations under the APA, the Employment Agreement, the NDA and all ancillary documents and agreements referenced or contemplated therein. In addition, within five business days of receipt of the Settlement Payment: (i) the Company will cause the Bilotti Arbitration to be dismissed, with prejudice; (ii) the Reliance Parties and Mr. Perrin will cause the Perrin Arbitration to be dismissed, with prejudice; and (iii) the Reliance Parties will cause the Lewis Litigation to be dismissed, with prejudice.

 

The information set forth above is qualified in its entirety by reference to the actual terms of the Settlement Agreement, a copy of which is attached hereto as Exhibit 10.1, and incorporated herein by reference.

 

Item 1.02. Termination of a Material Definitive Agreement.

 

The information set forth under Item 1.01 hereof is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Confidential Settlement and Mutual General Release Agreement, dated as of June 30, 2023, by and among the registrant, Medigap Healthcare Insurance Agency, LLC, Pagidem, LLC f/k/a Medigap Healthcare Insurance Company, LLC, Joseph J. Bilotti, III, Kyle Perrin, Zachary Lewis, T65 Health Insurance Solutions, Inc. f/k/a T65 Health Solutions, Inc., and Seniors First Life, LLC.
104   Cover Page Interactive Data File

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Reliance Global Group, Inc.
     
Dated: July 6, 2023 By:  /s/ Ezra Beyman
    Ezra Beyman
    Chief Executive Officer

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL RELEASE

 

This Confidential Settlement and Mutual General Release Agreement (this “Agreement”) is entered into effective as of June 30th, 2023 (the “Effective Date”) by and among (i) Reliance Global Group, Inc. (“RGG”), (ii) Medigap Healthcare Insurance Agency, LLC (“Agency,” and, together with RGG, the “Reliance Parties”), (iii) Pagidem, LLC f/k/a Medigap Healthcare Insurance Company, LLC (“Pagidem”), (iv) Joseph J. Bilotti, III (“Bilotti,” and, together with Pagidem, the “Bilotti Parties”), (v) Kyle Perrin (“Perrin”), (vi) Zachary Lewis (“Lewis”), (vii) T65 Health Insurance Solutions, Inc. f/k/a T65 Health Solutions, Inc. (“T65”), and (viii) Seniors First Life, LLC (“SFL,” and, together with Lewis and T65, the “Lewis Parties”). The Bilotti Parties, Perrin, and the Lewis Parties are collectively referred to herein as the “Medigap Parties.” Each of the parties shall be referred to individually as “Party,” and collectively referred to as the “Parties.”

 

WHEREAS, RGG, Pagidem, and Bilotti entered into the Asset Purchase Agreement dated December 21, 2021 (“APA”) under which RGG acquired, and the Bilotti Parties sold, certain assets and liabilities of Pagidem to RGG; and

 

WHEREAS, as part of the transactions contemplated by the APA, RGG and Perrin entered into the Employment Agreement dated as of January 10, 2022 (the “Employment Agreement”);

 

WHEREAS, RGG later assigned the assets and liabilities it acquired pursuant to the APA, and the Employment Agreement, to its wholly-owned subsidiary, Agency;

 

WHEREAS, Perrin previously served as the Chief Operating Officer and Chief Executive Officer of Agency pursuant to the Employment Agreement;

 

WHEREAS, RGG and Lewis entered into that certain Non-Disclosure Agreement, effective as of January 24, 2022 (the “NDA”);

 

WHEREAS, RGG, pursuant to the APA, has filed a claim with the American Arbitration Association (“AAA”), Case No. 01-23-0002-3404 (the “Bilotti Arbitration”), wherein RGG purports to assert claims against the Bilotti Parties for fraudulent inducement, intentional and negligent misrepresentation, breach of contract, breach of restrictive covenants, conversion, civil theft, tortious interference, and conspiracy (the “Bilotti Claim”);

 

WHEREAS, RGG, pursuant to the Employment Agreement, has filed a claim with the AAA, Case No. 01-23-0002-2048(the “Perrin Arbitration”), wherein RGG purports to assert claims against Perrin for conversion, civil conspiracy, fraud, breach of fiduciary duty, and breach of duty of loyalty and good faith. (the “Perrin Claim”);

 

WHEREAS, in the Perrin Arbitration, Perrin filed Counterclaims against RGG for breaches of employment agreement, unjust enrichment, and breach of the covenant of good faith and fair dealing (the “Perrin Counterclaim”);

 

1

 

 

WHEREAS, the Reliance Parties have filed a complaint in the Circuit Court of the 15th Judicial Circuit in and for Palm Beach County, Florida, Case No. 50-2023-CA-010777-XXXXMB, Div. AA (the “Lewis Litigation,” and, together with the Bilotti Arbitration and the Perrin Arbitration, the “Medigap Disputes”), wherein the Reliance Parties purport to assert claims against the Lewis Parties for Tortious Interference with Business Relationship, Civil Conspiracy, Breach of Contract, Conversion, and Unjust Enrichment (the “Lewis Claim”);

 

WHEREAS, the Parties have each disputed and continue to dispute the claims asserted and allegations made against them;

 

WHEREAS, United Insurance Group Agency, Inc. and/or LTC Global, Inc. or those entities’ assignees, affiliates, subsidiaries, partners or parent companies (collectively, the “Factor”), allege the Reliance Parties owe them a debt, which the Reliance Parties dispute;

 

WHEREAS, the Medigap Parties have not assisted the Factor in any way as against the Reliance Parties in the Factor’s alleged claim against the Reliance Parties;

 

WHEREAS, the Parties, without admitting any wrongdoing or any of the allegations made in the Medigap Disputes, in a good faith effort to avoid the cost and expense of protracted arbitration or litigation, and in the interest of resolving the Medigap Disputes and all other existing or potential disputes between them in an efficient and mutually beneficial manner, now desire to (1) settle, fully and finally, the Medigap Disputes and all duties and obligations owed pursuant to or implied by the APA, the Employment Agreement, the NDA and all ancillary documents and agreements referenced or contemplated therein (collectively, the “Documents”), (2) dismiss with prejudice all claims and counterclaims asserted in the Medigap Disputes, including, for the avoidance of doubt, the Bilotti Claim, Perrin Claim, Perrin Counterclaim, and Lewis Claim, (3) grant general mutual releases as set forth herein, and (4) terminate all remaining duties and obligations between and among each of the Parties as set forth in the Documents, including, without limitation, those duties and obligations owed pursuant to (a) Sections 8.3 and 8.4 of the APA, and (b) Sections 10 and 11 of the Employment Agreement; provided, however, nothing herein shall release or terminate the duties and obligations set forth herein, including, without limitation, the requirement of the Payor Parties (as defined below) to pay the Settlement Payment to the Reliance Parties when due as provided herein. For the avoidance of doubt, the Parties expressly intend to release all claims each may possess against the other, whether known or unknown, as of the Effective Date except as otherwise set forth herein.

 

NOW, THEREFORE, in consideration of the mutual promises and covenants made herein and intending to be legally bound, the Parties agree as follows:

 

1. Recitals. The Parties hereby incorporate the foregoing Recitals into this Agreement as if set forth herein and agree that the Recitals are true and correct.

 

2

 

 

2. Release.

 

a. Release by the Reliance Parties. Upon receipt of the Settlement Payment to the Reliance Parties, the Reliance Parties, on behalf of themselves and on behalf of their predecessors, successors, assignees, affiliates, parents, direct or indirect subsidiaries, shareholders, members, designees, partners, directors, officers, employees, agents, representatives, attorneys, insurers, spouses and heirs, do each hereby unconditionally, absolutely and irrevocably release, remise, acquit and forever settle, release and discharge each and all of the Bilotti Parties, Perrin, and the Lewis Parties, and each of their present and former agents, servants, or employees, members, owners, shareholders, officers, managers, partners, directors, trustees, representatives, attorneys, contractors, predecessor and successor entities and assigns, parents, subsidiaries and affiliates (collectively, the “Medigap Released Parties”) of and from any and all past, existing, and/or future suits, liabilities, claims, demands, fees, costs, expenses, payments, judgments, damages, actions and rights or causes of action of any kind or nature, from the beginning of the world to the Effective Date, whether arising in tort, by contract, by warranty, by statute, or otherwise, whether in law or in equity or otherwise, regardless of whether known or unknown, suspected or unsuspected, contingent or vested, patent or latent, accrued or not accrued as of the date of execution hereof relating to the Documents, the Medigap Disputes, and any other claims or causes of action based on any facts, circumstances, actions or omissions that occurred between the Reliance Parties and Medigap Released Parties, up to and including the Effective Date, including but not limited to (A) any matters that were or could have been alleged in the: (i) the Bilotti Arbitration; (ii) the Perrin Arbitration; (iii) the Lewis Litigation; and (B) (i) any and all claims to additional money, distributions, or compensation of any kind from the Medigap Released Parties; provided, however, that any obligations created by or set forth in this Agreement shall not be released; provided further, for the avoidance of doubt, that nothing herein shall serve to release any claims the Reliance Parties may have against the Factor.

 

b. Release by the Medigap Parties. Upon receipt of the Settlement Payment to the Reliance Parties, the Medigap Parties, on behalf of themselves and on behalf of their predecessors, assignees, affiliates, parents, direct or indirect subsidiaries, shareholders, members, designees, partners, directors, officers, employees, agents, representatives, attorneys, insurers, spouses and heirs, do each hereby unconditionally, absolutely and irrevocably release, remise, acquit and forever settle, release and discharge each and all of the Reliance Parties, and each of their present and former agents, servants, or employees, members, owners, shareholders, officers, managers, partners, directors, trustees, representatives, attorneys, contractors, predecessor and successor entities and assigns, parents, subsidiaries and affiliates (collectively, the “Reliance Released Parties”) of and from any and all past, existing, and/or future suits, liabilities, claims, demands, fees, costs, expenses, payments, judgments, damages, actions and rights or causes of action of any kind or nature, from the beginning of the world to the Effective Date, whether arising in tort, by contract, by warranty, by statute, or otherwise, whether in law or in equity or otherwise, regardless of whether known or unknown, suspected or unsuspected, contingent or vested, patent or latent, accrued or not accrued as of the date of execution hereof relating to the Documents, the Medigap Disputes, and any other claims or causes of action based on any facts, circumstances, actions or omissions that occurred between the Medigap Parties and Reliance Released Parties, up to and including the Effective Date, including but not limited to (A) any matters that were or could have been alleged in the: (i) the Bilotti Arbitration; (ii) the Perrin Arbitration; (iii) the Lewis Litigation; and (B) (i) any and all claims to additional money, distributions, or compensation of any kind from the Medigap Released Parties; provided, however, that any obligations created by or set forth in this Agreement shall not be released.

 

3

 

 

c. Release Related to Perrin’s Employment. In addition to the release provisions above, Mr. Perrin, individually, releases the Reliance Parties from all claims arising under any federal, state or local law or statute, including without limitation, the Fair Labor Standards Act, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Family Medical Leave Act, Title VII of the Civil Rights Act of 1964, Employee Retirement Income Security Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification Act, the law of contract and tort, any claim for attorneys’ fees, claims for unpaid wages or other employment compensation, and claims of personal injury, including mental and physical pain and suffering or intentional infliction of emotional distress. Additionally, Mr. Perrin expressly waives any right to recover any type of personal relief from the Reliance Parties, including monetary damages or reinstatement, in any administrative action or proceeding, whether state or federal, and whether brought by Mr. Perrin or on his behalf by an administrative agency, related in any way to the matters herein.

 

d. Attorneys’ Fees. Each of the Parties agrees (i) to bear any and all attorneys’ fees and costs it may have had, paid or incurred in connection with the Medigap Disputes or related to the Medigap Disputes, or the Documents and (ii) that none of the Parties shall be entitled to be a prevailing party against any other Party hereto and/or to recover any attorneys’ fees, costs or expenses from any other Party pursuant to any AAA rule, applicable law, the Documents or otherwise.

 

3. Payment of Settlement Amount. Within five (5) business days of the Effective Date, the Medigap Parties shall pay to RGG, in accordance with the wire instructions attached hereto as Exhibit A,an amount equal to $2,900,000 (the “Settlement Payment”). The Parties agree that, following the payment contemplated by this Section 3, none of the Medigap Released Parties shall have any further payment obligations to any of the Reliance Parties under any of the Documents or this Agreement.

 

4. Termination of Documents. Upon receipt of the Settlement Payment by the Reliance Parties, all of the Parties shall be fully, finally, and mutually discharged of any obligations under the Documents, including, without limitation, (a) Sections 8.3 and 8.4 of the APA, (b) Sections 10 and 11 of the Employment Agreement, and (c) any noncompete, nonsolicitation, nondisparagement and nondisclosure obligations, and such obligations shall be deemed terminated, released and waived. For the avoidance of doubt, each and all Parties to this Agreement hereby waive their rights to enforce any provisions terminated hereby as well as any and all amounts claimed to be owed or due to be owed under the Documents.

 

5. Dismissals with Prejudice. Within five (5) business days of Reliance Parties receipt of the Settlement Payment: (i) RGG shall cause the Bilotti Arbitration to be dismissed, with prejudice; (ii) the Reliance Parties and Perrin shall cause the Perrin Arbitration to be dismissed, with prejudice; and (iii) the Reliance Parties shall cause the Lewis Litigation to be dismissed, with prejudice. In each case, the Parties responsible for causing the aforementioned dismissals with prejudice shall state, to the AAA or the Court, as applicable, that each party to the arbitration or litigation shall bear its or his own fees and costs.

 

4

 

 

6. No Admissions. This Agreement represents the compromise and settlement of disputed claims and is not to be used or construed as an admission, direct or indirect, of any liability or wrongdoing whatsoever in any court or proceeding of any nature or in any subsequent actions by or among the Parties hereto.

 

7. Confidentiality. The Parties agree that the existence of this Agreement, and any and all terms of this Agreement, shall be kept confidential among the Parties, except: (1) as otherwise required by law, (2) as required by the rules of a stock exchange on which its securities are listed, (3) communications required by federal securities law, including the disclosure obligations under Section 13 and 15(d) of the Exchange Act of 1934, (4) communications with any Parties’ tax, accounting or legal professionals for the solicitation of advice, (5) communications with Reliance Parties’ board(s) of directors and/or shareholders, or (6) communications with a court of competent jurisdiction. The Parties agree there will be no publication or external disclosure of this settlement, and that this Agreement shall not be treated as an admission of liability by any Party hereto for any purpose. In addition, the Parties agree that the Medigap Parties will in no way assist the Factor in any investigation, claim or proceeding by them against the Reliance Parties.

 

8. Non-Disparagement. Each of the Parties agrees that it or he will not disparage or encourage or induce others to disparage any other Party or its business, products or services or former or current directors, officers or employees. The term “disparage” shall mean comments or statements on the internet or via social media, to the press and/or media, or to any individual or entity with whom any of the Parties has a prospective or existing business relationship, and which would adversely affect in any manner the Party’s prospective or existing business relationship or reputation. The Parties agree that a breach of this non-disparagement provision would cause the non-breaching party irreparable harm that is not compensable fully with money damages and therefore is appropriate for injunctive relief from a court of competent jurisdiction. This Section 8 shall not prohibit the Parties from communicating or testifying truthfully (i) to or with any government agencies and/or from cooperating with any such agency, (ii) pursuant to subpoena, (iii) as required by valid legal process or as otherwise required by law or (iv) in any action to challenge or enforce the terms of this Agreement.

 

9. Non-Interference. Each of the Medigap Parties agrees that it or he shall not, for a time period of twelve (12) months from the Effective Date, contact any person, known to be a current customer of the Reliance Parties, for the purpose of soliciting or diverting such customer from the Reliance Parties.

 

10. Dispute Resolution; Enforcement of this Agreement. All actions, proceedings, controversies or claims arising out of, or relating to, this Agreement, or the breach or interpretation thereof or the matters resolved hereby, must and shall be resolved exclusively state and federal courts located in Palm Beach County, Florida, which shall have exclusive jurisdiction. In the event of a dispute between the Parties involving the enforcement of the provisions of this Agreement, the prevailing party in such dispute shall be entitled to recover its reasonable costs and expenses, including reasonable attorneys’ fees and costs, incurred in connection with such dispute, any appeal thereof and any action taken to enforce the payment of the fees and costs pursuant to this Section 9.

 

5

 

 

11. Authority, Representations, Reliance. Each of the Parties represents and warrants (a) it is the sole owner of all claims released herein and that no portion of any action, claim, demand, cause of action, or other matter released herein has been assigned, pledged, or transferred to any other person or entity either directly or indirectly, voluntarily, involuntarily or by operation of law. The signatory for each Party represents and warrants he or she is a duly authorized representative with valid authority to sign for such Party and acknowledges that he or she has carefully read and fully understands all of the terms of this Agreement, including the release and obligations contained herein, and that he or she enters into this Agreement voluntarily, (b) has full legal capacity, power and authority to execute and deliver this Agreement and to perform its obligations hereunder, (c) this Agreement has been duly executed and delivered by such Party and is the legal, valid, and binding agreement of such, enforceable against it in accordance with the terms hereof, and (d) the execution of this Agreement and the performance of the obligations hereunder does not constitute (with or without notice or lapse of time or both) a default, breach or violation of any contract, written or oral, express or implied, to which such Party is a party or to which such Party is or may be bound. The Parties assume the risk of any and all claims for damages which exist as of this date, or that may exist in the future, but of which they do not know or suspect to exist, whether through ignorance, oversight, error, negligence, or otherwise, and which, if known, would materially affect the decision to enter into this Agreement voluntarily and with advice of counsel of their own choosing, and not in reliance on representations made by any of the other Parties. Each Party represents to the other Parties that they have had adequate time to seek counsel prior to signing this Agreement and enter into it of their own free will and after careful thought. OTHER THAN AS EXPRESSLY SET FORTH IN THIS AGREEMENT, NO PARTY MAKES ANY OTHER REPRESENTATION OR WARRANTY WHATSOEVER, EXPRESS OR IMPLIED, TO ANY OTHER PARTY OR PARTIES, AND NO PARTY HAS MADE, IS REQUIRED TO MAKE, AND/OR IS RELYING ON ANY DISCLOSURE FROM ANY OTHER PARTY HERETO, AND NO PARTY HAS RELIED ON ANY REPRESENTATION OR WARRANTY WHATSOEVER, EXPRESS OR IMPLIED, EXCEPT THOSE EXPRESSLY SET FORTH IN THIS AGREEMENT.

 

12. Miscellaneous.

 

a. Severability. The Parties agree the covenants and provisions contained in this Agreement are separate, severable and independent of each other, as each term and condition is based on viable and independent consideration and is of great importance to the Parties. Therefore, should any covenant or provision of this Agreement be declared invalid or unenforceable for any reason, the remaining covenants and other terms and conditions of this Agreement shall continue in full force and effect.

 

b. Successors and Assigns. All of the covenants, conditions and provisions of this Agreement, including the appendices attached hereto, shall be binding upon and shall inure to the benefit of the Parties hereto and their respective successors and assigns.

 

c. Entire Agreement. This Agreement contains the entire understanding of the Parties and supersedes all prior understandings and representations. This Agreement may not be modified or supplemented except by a subsequent written agreement signed by each of the Parties. Each of the signatories to this Agreement does hereby declare that the terms of this Agreement include a general release and have been completely read and are fully understood and voluntarily accepted for the purpose of making a full and final compromise settlement of all claims set forth above, disputed or otherwise, resulting from the aforementioned claims and damages, and it is specifically agreed that this Agreement shall be a complete bar between the Parties hereto as to all claims or suits of whatever nature relating to the Documents and the transactions contemplated thereby, and the Medigap Disputes, except for the obligations of the Parties under this Agreement.

 

6

 

 

d. Drafting. The Parties and their counsel have been free to comment on, add to, delete from, and to otherwise change this Agreement as they have seen fit. Any changes made have been at the request of one or more of the Parties to this Agreement (or their counsel) and represent the memorialization of their intent. The Parties hereto agree that in the event of any dispute as to the precise meaning of any term or provision contained herein, the principle of construction and interpretation that written documents are to be construed against the Party preparing the same shall not be applicable.

 

e. Form and Headings. Wherever used herein, the singular shall include the plural, the plural shall include the singular, and pronouns shall be read as masculine, feminine or neuter, all as the context requires. The headings used in this Agreement are for convenience and reference only and in no way define, describe, extend, or limit the scope or intent of this Agreement or the intent of any provision in it.

 

f. Governing Law. This Agreement shall be construed in accordance with the substantive laws of the State of Florida, without regard to conflicts of laws rules.

 

g. Original Signatures. A copy of this Agreement, which is signed and transmitted electronically, by facsimile, scan or telecopy machine shall be treated as and deemed to be an original document. The signature of any Party thereon, for purposes hereof, shall be considered as an original signature, and the document transmitted shall be considered to have the same binding effect as an original signature on an original document. At the request of any Party, any facsimile or telecopy documents shall be executed in original form by the Parties who executed the facsimile or telecopy document. No Party may raise the use of a facsimile or telecopy machine or the fact that any signature was transmitted through the use of a facsimile or telecopy machine as a defense to the enforcement of this Agreement or any amendment or other document executed in compliance with this Agreement.

 

h. Multiple Counterparts. This Agreement may be executed in multiple counterparts, each of which shall constitute an original hereof, all of which together shall constitute one and the same instrument. This Agreement may be executed by PDF signatures, which shall have the full force and effect as an original signature.

 

i. Effective Date. This Agreement shall become effective, final, and binding on the Effective Date.

 

j. Binding and Enforceable Agreement. Each Party waives and relinquishes any and all rights, under principles of law and equity, to rescind, vacate, or otherwise challenge this Agreement (including its making or enforceability), including but not limited to duress, coercion, unilateral mistake, mutual mistake, fraud in the inducement, or breach of any obligations or duties which any Party owed, or may have owed, any other Party from the beginning of the world to the date of this Agreement, arising under statutory or common law, or rule of procedure, including but not limited to disclosure or discovery obligations in any litigation between or among the Parties.

 

7

 

 

IN WITNESS WHEREOF, and intending to legally bind ourselves, our representatives, successors and assigns, the Parties herein set our hands and execute this Agreement on the date indicated below.

 

  Reliance Global Group, Inc.
     
  By: /s/ Ezra Beyman
  Its: CEO + Chairman
  Print Name: Ezra Beyman
  Date: 6/29/23

 

  Medigap Healthcare Insurance Agency, LLC
   
  By: /s/ Ezra Beyman
  Its: Manager
  Print Name: Ezra Beyman
  Date: 6/29/23

 

8

 

 

  Pagidem, LLC f/k/a Medigap Healthcare Insurance Company, LLC
     
  By: /s/ Joseph Bilotti III
  Its: Owner
  Print Name: Joseph Bilotti III
  Date: 6/30/23

 

  Joseph J. Bilotti III
   
  By: /s/ Joseph Bilotti III
  Date: 6/30/23
     
  Kyle Perrin
     
  By: /s/ Kyle Perrin
  Date: 6/30/23

 

9

 

 

  Zachary Lewis
   
  By: /s/ Zachary Lewis
  Date: 06/30/2023
     
  T65 Health Insurance Solutions, Inc. f/k/a T65 Health Solutions, Inc.
   
  By: /s/ Zack Lewis
  Its: CEO
  Print Name: Zack Lewis
  Date: 06/30/2023

 

     
  Seniors First Life, LLC
     
  By: /s/ Zack Lewis
  Its: CEO
  Print Name: Zack Lewis
  Date: 06/30/2023

 

10

 

 

EXHIBIT A1

 

From the Bilotti Parties to the Reliance Parties:

 

Amount: $1,933,333.34

Account Name:

Beneficiary Address:

Account Number:

Bank Name:

Bank ABA Number:

 

From Perrin to the Reliance Parties:

 

Amount: $ 966,666.66

Account Name:

Beneficiary Address:

Account Number:

Bank Name:

Bank ABA Number:

 

 

1 [To include Reliance’s wire instructions]

 

11

EX-101.SCH 3 reli-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 reli-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 5 reli-20230630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.086 par value per share Series A Warrants to purchase shares of Common Stock, par value $0.086 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 reli-20230630_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jun. 30, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 30, 2023
Entity File Number 001-40020
Entity Registrant Name Reliance Global Group, Inc.
Entity Central Index Key 0001812727
Entity Tax Identification Number 46-3390293
Entity Incorporation, State or Country Code FL
Entity Address, Address Line One 300 Blvd. of the Americas
Entity Address, Address Line Two Suite 105
Entity Address, City or Town Lakewood
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08701
City Area Code (732)
Local Phone Number 380-4600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, $0.086 par value per share  
Title of 12(b) Security Common Stock, $0.086 par value per share
Trading Symbol RELI
Security Exchange Name NASDAQ
Series A Warrants to purchase shares of Common Stock, par value $0.086 per share  
Title of 12(b) Security Series A Warrants to purchase shares of Common Stock, par value $0.086 per share
Trading Symbol RELIW
Security Exchange Name NASDAQ
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001812727 2023-06-30 2023-06-30 0001812727 RELI:CommonStock0.086ParValuePerShareMember 2023-06-30 2023-06-30 0001812727 RELI:SeriesWarrantsToPurchaseSharesOfCommonStockParValue0.086PerShareMember 2023-06-30 2023-06-30 iso4217:USD shares iso4217:USD shares 0001812727 false 8-K 2023-06-30 Reliance Global Group, Inc. FL 001-40020 46-3390293 300 Blvd. of the Americas Suite 105 Lakewood NJ 08701 (732) 380-4600 false false false false Common Stock, $0.086 par value per share RELI NASDAQ Series A Warrants to purchase shares of Common Stock, par value $0.086 per share RELIW NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://relianceglobalgroup.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex10-1.htm reli-20230630.xsd reli-20230630_def.xml reli-20230630_lab.xml reli-20230630_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "reli-20230630_def.xml" ] }, "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "reli-20230630_lab.xml" ] }, "presentationLink": { "local": [ "reli-20230630_pre.xml" ] }, "schema": { "local": [ "reli-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 2, "memberStandard": 0, "nsprefix": "RELI", "nsuri": "http://relianceglobalgroup.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://relianceglobalgroup.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "RELI_CommonStock0.086ParValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.086 par value per share" } } }, "localname": "CommonStock0.086ParValuePerShareMember", "nsuri": "http://relianceglobalgroup.com/20230630", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "domainItemType" }, "RELI_SeriesWarrantsToPurchaseSharesOfCommonStockParValue0.086PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Warrants to purchase shares of Common Stock, par value $0.086 per share" } } }, "localname": "SeriesWarrantsToPurchaseSharesOfCommonStockParValue0.086PerShareMember", "nsuri": "http://relianceglobalgroup.com/20230630", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://relianceglobalgroup.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001493152-23-023865-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-023865-xbrl.zip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end